Products and solutions
ErbaLisa COVID IgM
What you might be interested in:
Advisory notices:
|26.03.2021| AN 2021_02 CREA ENZ 200
More »
News:
|02.12.2020| Limited work operation in Erba Lachema
More »
Send a question

ErbaLisa COVID IgM

Last update: 07.05.2021, 10:10:47
ErbaLisa COVID-19 IgM
CE-marked Enzyme Immunoassay (ELISA) kit for the detection of IgM antibodies to SARS-CoV-2 in human serum.
 
Main Features:
Number of tests: 96
Principle: Indirect ELISA using recombinant Spike (S) subunit and Nucleocapsid (N) antigens
Tracer: HRP-Labelled Anti-human IgM
Assay format: Semi-quantitative
Total incubation time: 50 minutes
Sample type: Serum
Sample volume: 10 μL
Sample Size: 100 μL (1:21 Dilution)
Reading wavelength: 450nm
Storage: 2-8ºC
Built for convenience:
Ready to use reagents
Removable strips
Break-apart wells
All incubation steps at room temperature
Interchangeable reagents
Calibrator and Controls included
Ready for automation
1:21 sample dilution can be performed validated on microwell plate
 
Performance characteristics:
30 serum samples collected from previously RT-PCR confirmed COVID-19 patients were tested. 50 normal  healthy patients with samples collected before COVID-19 outbreak (prior to December 2019) were tested. The results are as follows:
 
Validation conducted in the USA.
 
Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus.
Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.

Photo gallery


Downloadable documents

Catalogues & Brochures:

From our events: | MEDICA 2018 | As always, Erba Mannheim took part in MEDICA fair...
More »